THE ULTIMATE GUIDE TO PHARMACEUTICAL INGREDIENTS

“The current circumstance has uncovered some structural weaknesses while in the EU’s medicines provide chain along with a higher dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides reported. She recommended that supply chain challenges be resolved within an EU pharmaceutical approach expected to generally be laun